Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (19786)	4/29/1998 12:14:00 AM
From: Scott H. Davis	Read Replies (2) \| Respond to of 32384

Bluejeans, thanks for the links. In regards to the biotech report I'm preparing: 1. It's taking far longer than I thought (but I'm learning a lot) 2. The urgancy is decreased since the Rational Analyst thread is weighted towards a TA approach, and right now the Biotech sector is technically weak - not a good time for advocating biotechs there. 3. A friend of mine recently had surgery for removal of a fairly large tumor (re-occurance of Melanoma) So I'm also spreading my research out and looking at biotech with phase II or III trials for promising maintenance therapies. Drs. estimage her chance of a re-occurance at 85%, so a maintenance med seems to be indicated VICL's cancel therapies look like they may be promising - I'm going to call them this week. Do you know any others I should check out? Any help will be greatly appreciated. Scott